BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, December 20, 2025
See today's BioWorld
Home
» Regulatory actions for July 30, 2020
To read the full article
sign up for free
or
sign in
.
Regulatory actions for July 30, 2020
July 30, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adocia, Astrazeneca, Aytu, Bluebird, BMS, Celltrion, Direct, Diurnal, Dynacure, Edesa, Eton, Imago, Marinus, Merck, Poxel, Siga, Sumitomo, Synthetic, Takeda.
BioWorld
Briefs
Regulatory
Regulatory actions
Coronavirus